Status:
COMPLETED
Optimized Perioperative Antibiotic Prophylaxis in Radical Cystectomy
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Radical Cystectomy
Surgical Site Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cystectomy with urinary diversion (ileal conduit, orthotopic ileal bladder substitute, continent catheterizable pouch) is the best treatment option for patients with muscle-invasive bladder cancer. Th...
Eligibility Criteria
Inclusion
- Written informed consent
- Age \>18 years
- Planned radical cystectomy at the Department of Urology, Bern University Hospital
Exclusion
- Contraindications to the classes of drugs under study, e.g. known hypersensitivity or allergy to class of drugs including alternatives described in the protocol or the investigational product,
- Women who are pregnant or breast feeding (exclusion for surgery),
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
- Previous enrolment into the current study,
- Enrolment of the investigator, his/her family members, employees and other dependent persons,
Key Trial Info
Start Date :
April 9 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2024
Estimated Enrollment :
196 Patients enrolled
Trial Details
Trial ID
NCT03305627
Start Date
April 9 2018
End Date
February 28 2024
Last Update
May 8 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Infectious Diseases, University Hospital Bern
Bern, Switzerland, 3010
2
Department of Urology, University Hopspital Bern
Bern, Switzerland, 3010